Alkem Laboratories Limited annual revenue for fiscal 2026 was ₹145.3 billion, an increase of 13.5% from ₹128.0 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Revenue (annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹145.3B | ₹128.0B | ₹124.4B | ₹114.4B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Revenue (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Total Revenue | ₹37.4B | ₹36.0B | ₹37.4B | ₹40.0B | ₹33.7B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ALKEM metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow
All ALKEM financial statements → Interactive ALKEM charts →
About TickerBase · Data methodology & sources · Privacy · Terms